Evidence map›Paper›PMID 33180827›Full record

ArticlePloS one2020

Hydrogen sulfide facilitates reprogramming and trans-differentiation in 3D dermal fibroblast.

Elena A Ostrakhovitch, Shin Akakura, Siamak Tabibzadeh

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elena A OstrakhovitchFrontiers in Bioscience Research Institute in Aging and Cancer, Irvine, CA, United States of America.
Shin AkakuraFrontiers in Bioscience Research Institute in Aging and Cancer, Irvine, CA, United States of America.
Siamak TabibzadehFrontiers in Bioscience Research Institute in Aging and Cancer, Irvine, CA, United States of America.ORCID 0000-0001-8419-7223
Bioscience Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficiency of cell reprogramming in two-dimensional (2D) cultures is limited. Given that cellular stemness is intimately related to microenvironmental changes, 3D cell cultures have the potential of overcoming this limited capacity by allowing cells to self-organize by aggregation. In 3D space, cells interact more efficiently, modify their cellular topology, gene expression, signaling, and metabolism. It is yet not clear as how 3D culture environments modify the reprogramming potential of fibroblasts. We demonstrate that 3D spheroids from dermal fibroblasts formed under ultra-low attachment conditions showed increased lactate production. This is a requisite for cell reprogramming, increase their expression of pluripotency genes, such as OCT4, NANOG and SOX2, and display upregulated cystathionine-β-synthase (CBS) and hydrogen sulfide (H2S) production. Knockdown of CBS by RNAi suppresses lactic acid and H2S production and concomitantly decreases the expression of OCT4 and NANOG. On the contrary, H2S donors, NaHS and garlic-derived diallyl trisulfide (DATS), promote the expression of OCT4, and support osteogenic trans-differentiation of fibroblasts. These results demonstrate that CBS mediated release of H2S regulates the reprogramming of dermal fibroblasts grown in 3D cultures and supports their trans-differentiation.

Indexed as

Cell TransdifferentiationCellular ReprogrammingAllyl CompoundsCells, CulturedCellular Reprogramming TechniquesCystathionine beta-SynthaseFibroblastsHumansHydrogen SulfideLactic AcidNanog Homeobox ProteinOctamer Transcription Factor-3OsteoblastsSOXB1 Transcription FactorsSpheroids, CellularSulfidesAllyl CompoundsCystathionine beta-Synthasediallyl trisulfideHydrogen SulfideLactic AcidNanog Homeobox ProteinNANOG protein, humanOctamer Transcription Factor-3POU5F1 protein, humansodium bisulfideSOX2 protein, humanSOXB1 Transcription FactorsSulfides

Identifiers

PMID33180827
PMCPMC7660576
OpenAlexW3102738091

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.